Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 187M | 52M | 50M | 63M | 58M | 42M |
| Cost of revenue | — | — | — | — | — | 57M |
| Research and development | 6M | — | — | 911,000 | — | — |
| Selling, general and administrative | 51M | 20M | 16M | 16M | 12M | 11M |
| Operating expenses | 226M | 68M | 79M | 73M | 72M | 69M |
| Operating income | −39M | −15M | −29M | −10M | −14M | −28M |
| Pre-tax income | −53M | −10M | −38M | 975,000 | −80M | 17M |
| Income tax | 2,000 | 5,000 | 0 | 0 | 50,000 | 0 |
| Net income | −37M | −7M | −25M | −11M | −55M | 19M |
| Earnings per share | −0.25 | −0.06 | −0.22 | −0.11 | −0.83 | 0.34 |
| Earnings per share, diluted | −0.25 | −0.06 | −0.22 | −0.11 | −0.83 | 0.30 |
| Weighted average shares | 148M | 118M | 117M | 107M | 67M | 55M |
| Weighted average shares, diluted | 148M | 118M | 117M | 107M | 67M | 62M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 232M | 583M | 622M | 345M | 373M | 208M | 90M | 32M |
| Receivables | 106M | 12M | 23M |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | −55M | — | — | 19M | — | — |
| Depreciation and amortisation | 13M | 815,000 | 752,000 | 623,000 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 37M |
| 29M |
| 45M |
| 51M |
| 38M |
| Inventory | 58M | 0 | — | — | — | — | — | — |
| Current assets | 505M | 619M | 666M | 397M | 431M | 293M | 168M | 83M |
| Property, plant and equipment | 244M | 69M | 49M | 41M | 30M | 23M | 17M | 21M |
| Goodwill | 380M | 19M | — | — | — | 0 | — | — |
| Total assets | 1.72B | 757M | 754M | 476M | 500M | 355M | 225M | 140M |
| Current liabilities | 415M | 125M | 106M | 107M | 98M | 99M | 95M | 85M |
| Short-term debt | — | — | — | — | — | 0 | 0 | 3M |
| Long-term debt | 336M | 335M | 335M | — | — | 0 | — | — |
| Total liabilities | 987M | 553M | 510M | 185M | 172M | 351M | 229M | 150M |
| Equity | −334M | −755M | −404M | −379M | −135M | −1.01B | −495M | −229M |
| Treasury shares | 2M | 2M | 2M | 2M | 2M | 2M | 1M | 1M |
| 482,000 |
| 423,000 |
| Share-based compensation | 9M | — | — | 3M | — | — |
| Capital expenditure | 10M | — | — | 6M | — | — |
| Investing cash flow | −455M | — | — | −6M | — | — |
| Share buybacks | 0 | — | — | 21M | — | — |
| Financing cash flow | 167M | — | — | 152M | — | — |